- Udyam number
- UDYAM-OD-26-0009072

Abd Drugs Private Limited
About Abd Drugs Private Limited
Data last updated:
Abd Drugs Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 May 2022.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51909OR2022PTC039620. Its GSTIN is 21AAWCA9433C1ZP (Odisha).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Srimanta Kumar Khatoi and Suneet Mohapatra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Duplex – 18 3rd Floor Rm – 3 Pubasasan, Bhubaneswar, Odisha, India – 751002.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.32 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹7.26 Lakh (net margin 0.6%) and EBITDA of ₹21.21 Lakh (EBITDA margin 1.9%).
As per MCA filings, the company has open charges of ₹1.7 Cr on record.
Abd Drugs Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-OD-26-0009072).
Company details
Recognitions & Rankings of Abd Drugs
Contact details
Abd Drugs Private Limited's registered office is in Bhubaneswar, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDuplex – 18 3rd Floor Rm – 3 Pubasasan, Bhubaneswar, Odisha, India – 751002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Abd Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Abd Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Abd Drugs Private Limited, buy the company report.
Financials of Abd Drugs Private Limited
FY 2025 filings availableAbd Drugs Private Limited reported revenue of ₹11.32 Cr (up 168% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 168% in the latest year. EBITDA rose 295% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹21.21 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹7.26 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.9% | ||
| Net Profit Margin | 0.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Abd Drugs Private Limited, buy the company report.
Board of directors of Abd Drugs Private Limited
Abd Drugs has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srimanta Kumar Khatoi | Director | 12 Dec 2023 | 2 Years 10 Months | Current |
| Suneet Mohapatra | Director | 25 Apr 2024 | 2 Years 6 Months | Current |
Auditor
Abd Drugs Private Limited is audited by PBSD & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PBSD & ASSOCIATES | FY 2023 | 069913 |
Shareholding
The shareholding of Abd Drugs Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Abd Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jun 2024 | 100947779 | Bank of India | ₹1.7 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Abd Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Abd Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Abd Drugs Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
Abd Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAWCA9433C1ZP | Odisha | Active | 21 May 2022 |
To see the full GST registrations and return filing status of Abd Drugs Private Limited, buy the company report.
Recent activity
Abd Drugs Private Limited has 8 board changes on record since 2022: 5 appointments and 3 cessations. The latest: Deepak Kumar Pani ceased to be Managing Director on 26 Apr 2024.
Frequently asked questions
Abd Drugs is an active private limited company based in Bhubaneswar, Odisha, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 May 2022 (4+ years old) and is registered under CIN U51909OR2022PTC039620.
Abd Drugs has 2 current directors:
- Srimanta Kumar Khatoi - Director
- Suneet Mohapatra - Director
The latest financial statements of Abd Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Abd Drugs is 21AAWCA9433C1ZP, registered in Odisha.
The CIN (Corporate Identification Number) of Abd Drugs is U51909OR2022PTC039620. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abd Drugs was incorporated on 04 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Cuttack.
Deepak Kumar Pani ceased to be Managing Director on 26 Apr 2024. Suneet Mohapatra was appointed as Director on 25 Apr 2024. Srimanta Kumar Khatoi was appointed as Director on 12 Dec 2023. Abd Drugs has 8 board changes on record in total.
Yes, Abd Drugs is registered as an MSME under Udyam registration (number: UDYAM-OD-26-0009072).
The registered office of Abd Drugs is at Duplex – 18 3rd Floor Rm – 3 Pubasasan, Bhubaneswar, Odisha, India – 751002.
Abd Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

